Stay updated through our LinkedIn!
Press releases
Red light therapy device to feature at Myopia Progression in Children Conference 2023
Eyerising International will have its red light therapy device on display at the 2023 Myopia Progression in Children Conference (MPIC), featuring alongside many other new therapeutic interventions at the all-day event taking place in Sydney[...]
Shifting The Myopia Management Paradigm With Repeated Low-Level Red Light Therapy — Prof He Mingguang
Light exposure from spending time outdoors has been proven to prevent and slow down myopia. There is now an evidence-based medical device delivering low-level red light therapy that can help children reduce and even reverse[...]
The world’s first evidence-based, home-use, red-light therapy to manage myopia launched at the Asia Pacific Academy of Ophthalmology Congress (APAO) 2023 in Kuala Lumpur
The world’s first evidence-based, home-use, red-light therapy to manage myopia launched at the Asia Pacific Academy of Ophthalmology Congress (APAO) 2023 in Kuala Lumpur The patented Eyerising Myopia Management Device system has been clinically proven[...]
Axial Shortening in Myopic Children after Repeated Low-Level Red-Light Therapy: Post Hoc Analysis of a Randomized Trial
Axial length (AL) elongation in myopia is considered irreversible. We aimed to systemically report unexpected AL shortening observed in a randomized clinical trial (RCT) after repeated low-level red-light (RLRL) therapy. See full article >
